• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响乙醇注入法制备脂质体粒径的因素。

Factors affecting liposomes particle size prepared by ethanol injection method.

作者信息

Shaker Sherif, Gardouh Ahmed Rifaat, Ghorab Mamdouh Mostafa

机构信息

Department of Pharmaceutical Research, Faculty of Pharmacy and Drug Technology, Heliopolis University for Sustainable Development, 2834 El Horreya, Cairo, Egypt.

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt.

出版信息

Res Pharm Sci. 2017 Oct;12(5):346-352. doi: 10.4103/1735-5362.213979.

DOI:10.4103/1735-5362.213979
PMID:28974972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5615864/
Abstract

Ethanol injection is one of the techniques frequently used to produce liposomes which favors both simplicity and safety. In this process, an ethanolic solution of lipids is rapidly injected into an aqueous medium through a needle, dispersing the phospholipids throughout the medium and promoting the vesicle formation. Being a critical parameter that determines the fate of liposome and its distribution, we studied different factors affecting the particle size of liposomes including different phospholipid (Phosal 53 MCT) and cholesterol concentrations and the use of different types of non-ionic surfactants at fixed Phosal 53 MCT concentration of 50 mg per formulation. Both Phosal 53 MCT and cholesterol concentration had direct effect on liposomes particle size. Non-ionic surfactants produced liposomes of smaller particle size when compared to conventional liposomes formed using Phosal 53 MCT 300 mg per formulation only, whereas this effect was diminished when higher Phosal 53 MCT to cholesterol ratios were used that obviously increased liposomes size. Smaller liposomes sizes were obtained upon using non-ionic surfactants of lower hydrophilic/hydrophobic balance (HLB) as both Tween 80 and Cremophor RH 40 produced liposomes of smaller particle size compared to Poloxamer 407. The smallest liposomes particle size was successfully obtained in the formulation comprising 300 mg Phosal MCT, 150 mg cholesterol and 50 mg Tween 80.

摘要

乙醇注入法是常用于制备脂质体的技术之一,该方法兼具简便性与安全性。在此过程中,脂质的乙醇溶液通过针头快速注入水相中,使磷脂分散于整个介质中并促进囊泡形成。作为决定脂质体命运及其分布的关键参数,我们研究了不同因素对脂质体粒径的影响,包括不同的磷脂(Phosal 53 MCT)和胆固醇浓度,以及在每制剂固定Phosal 53 MCT浓度为50 mg的情况下使用不同类型的非离子表面活性剂。Phosal 53 MCT和胆固醇浓度均对脂质体粒径有直接影响。与仅使用每制剂300 mg Phosal 53 MCT形成的传统脂质体相比,非离子表面活性剂产生的脂质体粒径更小,然而当使用更高的Phosal 53 MCT与胆固醇比例时,这种效果会减弱,这明显增加了脂质体的大小。使用亲水/亲油平衡(HLB)较低的非离子表面活性剂可获得较小的脂质体粒径,因为与泊洛沙姆407相比,吐温80和聚氧乙烯蓖麻油RH 40产生的脂质体粒径更小。在包含300 mg Phosal MCT、150 mg胆固醇和50 mg吐温80的制剂中成功获得了最小的脂质体粒径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a031/5615864/4440bc6dfb48/RPS-12-346-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a031/5615864/ab22351fdbd0/RPS-12-346-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a031/5615864/c0312c7eed62/RPS-12-346-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a031/5615864/4440bc6dfb48/RPS-12-346-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a031/5615864/ab22351fdbd0/RPS-12-346-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a031/5615864/c0312c7eed62/RPS-12-346-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a031/5615864/4440bc6dfb48/RPS-12-346-g003.jpg

相似文献

1
Factors affecting liposomes particle size prepared by ethanol injection method.影响乙醇注入法制备脂质体粒径的因素。
Res Pharm Sci. 2017 Oct;12(5):346-352. doi: 10.4103/1735-5362.213979.
2
Dermal delivery of selected hydrophilic drugs from elastic liposomes: effect of phospholipid formulation and surfactants.从弹性脂质体进行特定亲水性药物的皮肤给药:磷脂配方和表面活性剂的影响。
J Pharm Pharmacol. 2007 Sep;59(9):1215-22. doi: 10.1211/jpp.59.9.0005.
3
Formulation and Pharmacokinetic Evaluation of Phosal Based Zaltoprofen Solid Self-Nanoemulsifying Drug Delivery System.基于磷酰酯的扎托洛芬固体自纳米乳化药物递送系统的制剂与药代动力学评价
Pharm Nanotechnol. 2019;7(4):328-338. doi: 10.2174/2211738507666190802141754.
4
Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.通过乙醇注入法制备的含新型喜树碱类似物(吉马替康)的脂质体。
J Liposome Res. 2004;14(1-2):87-109. doi: 10.1081/lpr-120039794.
5
Manufacture of liposomes by isopropanol injection: characterization of the method.异丙醇注入法制备脂质体:方法学表征。
J Liposome Res. 2012 Mar;22(1):18-30. doi: 10.3109/08982104.2011.584318. Epub 2011 Jun 24.
6
Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.采用析因设计法开发负载维生素的局部脂质体制剂:药物沉积与稳定性
Int J Pharm. 2006 Aug 31;320(1-2):37-44. doi: 10.1016/j.ijpharm.2006.04.001. Epub 2006 Apr 7.
7
Modified and derived ethanol injection toward liposomes: development of the process.改良和衍生的乙醇注入法制备脂质体:工艺开发。
J Liposome Res. 2013 Mar;23(1):11-9. doi: 10.3109/08982104.2012.717298. Epub 2012 Oct 1.
8
Precise control of liposome size using characteristic time depends on solvent type and membrane properties.使用特征时间精确控制脂质体大小取决于溶剂类型和膜性质。
Sci Rep. 2023 Mar 23;13(1):4728. doi: 10.1038/s41598-023-31895-z.
9
Properties of various phospholipid mixtures as emulsifiers or dispersing agents in nanoparticle drug carrier preparations.各种磷脂混合物在纳米颗粒药物载体制剂中作为乳化剂或分散剂的性质。
Colloids Surf B Biointerfaces. 2005 Apr 10;41(4):257-62. doi: 10.1016/j.colsurfb.2004.12.018.
10
Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation.乙醇注入法制备亲水性和亲脂性载药脂质体。
J Liposome Res. 2010 Sep;20(3):228-43. doi: 10.3109/08982100903347923.

引用本文的文献

1
Exploring topical atorvastatin hyalurosomal gel as an adjuvant for reducing systemic corticosteroid dosage: a randomized clinical trial in severe oral lichen planus patients.探索局部用阿托伐他汀透明质酸凝胶作为减少全身皮质类固醇剂量的辅助药物:一项针对重度口腔扁平苔藓患者的随机临床试验。
Drug Deliv Transl Res. 2025 Sep 5. doi: 10.1007/s13346-025-01956-z.
2
Development of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation.用于透皮给药的载缬沙坦纳米脂质体快速溶解微针的研制:体外和离体评价
Pharmaceutics. 2025 Apr 7;17(4):483. doi: 10.3390/pharmaceutics17040483.
3

本文引用的文献

1
Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes.电荷、碳链长度及表面活性剂含量对载美洛昔康脂质体透皮性能的影响
Int J Nanomedicine. 2014 Apr 29;9:2005-17. doi: 10.2147/IJN.S60674. eCollection 2014.
2
Formulation and evaluation of celastrol-loaded liposomes.载姜黄素脂质体的制备与评价。
Molecules. 2011 Sep 13;16(9):7880-92. doi: 10.3390/molecules16097880.
3
Liposome technology for industrial purposes.用于工业目的的脂质体技术。
Eco-friendly Nanostructured Liquid Crystals Loaded with Clove Oil as a Sustainable Approach for Managing Infected Burn Wounds.
负载丁香油的环保型纳米结构液晶作为处理感染烧伤创面的可持续方法
AAPS PharmSciTech. 2024 Dec 17;26(1):15. doi: 10.1208/s12249-024-03009-z.
4
Computational Designed and Optimized Liposomal Curcumin-Embedded Bifunctional Cross-Linked Hydrogels for Wound Healing.用于伤口愈合的计算设计和优化的载姜黄素脂质体双功能交联水凝胶
Gels. 2024 Sep 18;10(9):598. doi: 10.3390/gels10090598.
5
Follicular mediated etodolac phosalosomal gel for contact dermatitis alleviation, insights from optimization to in-vivo appraisal.用于接触性皮炎缓解的滤泡介导依托度酸磷脂体凝胶:从优化到体内评价的见解。
Sci Rep. 2024 Sep 18;14(1):21744. doi: 10.1038/s41598-024-71456-6.
6
Pea protein-coated nanoliposomal encapsulation of jujube phenolic extract with different stabilizers; characterization and release.不同稳定剂存在下枣酚类提取物的豌豆蛋白包被纳米脂质体包封;表征与释放
Food Chem X. 2024 Aug 24;23:101771. doi: 10.1016/j.fochx.2024.101771. eCollection 2024 Oct 30.
7
BrSPR-20-P1 peptide isolated from sp. developed into liposomal hydrogel as a potential topical antimicrobial agent.从[具体物种]分离出的BrSPR-20-P1肽被开发成脂质体水凝胶,作为一种潜在的局部抗菌剂。
RSC Adv. 2024 Aug 28;14(37):27394-27411. doi: 10.1039/d4ra03722g. eCollection 2024 Aug 22.
8
Assembly of In-Situ Gel Containing Nano-Spanlastics of an Angiotensin II Inhibitor as a Novel Epitome for Hypertension Management: Factorial Design Optimization, In-vitro Gauging, Pharmacokinetics, and Pharmacodynamics Appraisal.原位凝胶载纳米沙坦的组装作为高血压管理的新典范:基于因子设计优化、体外评估、药代动力学和药效学评价。
AAPS PharmSciTech. 2024 May 16;25(5):115. doi: 10.1208/s12249-024-02823-9.
9
Enhancing the efficacy of letrozole-loaded PEGylated nanoliposomes against breast cancer cells: study.增强载有来曲唑的聚乙二醇化纳米脂质体对乳腺癌细胞的疗效:研究
Heliyon. 2024 Apr 30;10(9):e30503. doi: 10.1016/j.heliyon.2024.e30503. eCollection 2024 May 15.
10
Dynamic intervention to enhance the stability of PEGylated Ibrutinib loaded lipidic nano-vesicular systems: transitioning from colloidal dispersion to lyophilized product.动态干预增强载有 PEG 伊布替尼的脂质纳米囊泡系统的稳定性:从胶体分散体向冻干产品的转变。
Drug Deliv Transl Res. 2024 Nov;14(11):3269-3290. doi: 10.1007/s13346-024-01555-4. Epub 2024 Mar 8.
J Drug Deliv. 2011;2011:591325. doi: 10.1155/2011/591325. Epub 2010 Dec 5.
4
Phospholipids and lipid-based formulations in oral drug delivery.磷脂及基于脂质的口服递药系统
Pharm Res. 2010 Aug;27(8):1469-86. doi: 10.1007/s11095-010-0130-x. Epub 2010 Apr 22.
5
Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation.乙醇注入法制备亲水性和亲脂性载药脂质体。
J Liposome Res. 2010 Sep;20(3):228-43. doi: 10.3109/08982100903347923.
6
Lipid nanoparticles for parenteral delivery of actives.用于活性成分肠胃外给药的脂质纳米颗粒。
Eur J Pharm Biopharm. 2009 Feb;71(2):161-72. doi: 10.1016/j.ejpb.2008.09.003. Epub 2008 Sep 13.
7
Caffeine-loaded niosomes: characterization and in vitro release studies.载咖啡因的非离子表面活性剂囊泡:表征及体外释放研究
Drug Deliv. 2007 Oct;14(7):447-52. doi: 10.1080/10717540701603597.
8
Evaluation of the antimicrobial and antioxidant activities of Origanum dictamnus extracts before and after encapsulation in liposomes.牛至提取物包封于脂质体前后的抗菌和抗氧化活性评估。
Molecules. 2007 May 2;12(5):932-45. doi: 10.3390/12050932.
9
Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy.利用原子力显微镜对云母表面含胆固醇脂质体的力学性能和稳定性进行测量。
J Colloid Interface Sci. 2004 Oct 1;278(1):53-62. doi: 10.1016/j.jcis.2004.05.042.
10
Single bilayer liposomes prepared without sonication.未经过超声处理制备的单层脂质体。
Biochim Biophys Acta. 1973 Apr 16;298(4):1015-9. doi: 10.1016/0005-2736(73)90408-2.